TEZUSOMANT
UNII P76WKQ7R9F

Substance Identification & Data

This profile provides standardized clinical and technical data for Tezusomant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P76WKQ7R9F.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2802416-72-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P76WKQ7R9F

CAS Registry Number

2802416-72-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TEZUSOMANT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C120H171N23O32S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UUNQJTVHPFMQJB-OMRBBKOSSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C215246

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

172866519

Unique identification number in the NCBI database of chemical substances.

INN ID

13406

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O=C1[C@@H]2Cc3c4c(cccc4)n(CC(=O)NCCCC[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N2)N(C)C(=O)[C@H](Cc5ccc(C(O)=O)cc5)NC(=O)CSC[C@@H](C(NCCCC[C@H](NC(CC[C@H](NC(CC[C@H](NC(CCCCCCCCCCCCCCC(O)=O)=O)C(O)=O)=O)C(O)=O)=O)C(N)=O)=O)NC(=O)[C@H](C(C)C)NC(=O)C(C)(C)NC(=O)[C@H](Cc6c7c(ccc(O)c7)[nH]c6)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc8ccc(C(O)=O)cc8)N1)c3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tezusomant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEZUSOMANT

Common Names & Synonyms

L-LYSINAMIDE, N-(15-CARBOXY-1-OXOPENTADECYL)-L-.GAMMA.-GLUTAMYL-L-.GAMMA.-GLUTAMYL-N6-(4-CARBOXY-N-(2-MERCAPTOACETYL)-L-PHENYLALANYL-N2-METHYL-L-LYSYL-L-VALYL-L-VALYL-L-SERYL-L-ASPARAGINYL-1-(CARBOXYMETHYL)-L-TRYPTOPHYL-4-CARBOXY-L-PHENYLALANYL-L-LYSYL-5-HYDROXY-L-TRYPTOPHYL-2-METHYLALANYL-L-VALYL-L-CYSTEINYL)-, (7'->2')-LACTAM, CYCLIC (1'->13')-THIOETHER

N-(15-CARBOXYPENTADECANOYL)-L-.GAMMA.-GLUTAMYL-L-.GAMMA.-GLUTAMYL-N6-(N6.2,C1.7-ANHYDRO-SN.1,C3.13-CYCLO(4-CARBOXY-N-(SULFANYLACETYL)-L-PHENYLALANYL-N2-METHYL-L-LYSYL-L-VALYL-L-VALYL-L-SERYL-L-ASPARAGINYL-1-(CARBOXYMETHYL)-LTRYPTOPHYL-4-CARBOXY-L-PHENYLALANYL-L-LYSYL-5-HYDROXY-L-TRYPTOPHYL-2-METHYLALANYL-L-VALYL-L-ALANYL))-L-LYSINAMIDE

TEZUSOMANT [INN]

External Clinical & Regulatory Resources

Previous UNIIP76N676YZ5

Next UNIIP771FDQ1WJ